Arjo ABSTU:A39 +1.53%68 EV-to-FCF is 4.74 as of Jul. 02, 2026, which is 54% below its 10-year median of 10.24. GuruFocus rates STU:A39 with a GF Score™ of 68/100 and a GF Value™ of €3.41 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 75 Medical Distribution companies, Arjo AB ranks better than 89.33% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Arjo AB's Enterprise Value is €645.8 Mil.
Arjo AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €136.3 Mil. Therefore, Arjo AB's EV-to-FCF for today is 4.74.
The historical rank and industry rank for Arjo AB's EV-to-FCF or its related term are showing as below:
STU:A39'
s EV-to-FCF Range Over the Past 10 Years
Min: 4.61 Med: 10.24 Max: 22.79
Current: 4.79
During the past 13 years, the highest EV-to-FCF of Arjo AB was 22.79. The lowest was 4.61. And the median was 10.24.
STU:A39's EV-to-FCF is ranked better than 89.33% of 75
companies
in the Medical Distribution industry
Industry Median: 16.34
vs STU:A39: 4.79
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Arjo AB's share price for today is €2.252.
Arjo AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.119.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Arjo AB EV-to-FCF Related Terms
Arjo AB EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Arjo AB's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Arjo AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arjo AB EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Arjo AB's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Arjo AB's EV-to-FCF falls into.
Arjo AB's current Enterprise Value is €645.8 Mil.
Arjo AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €136.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arjo AB (STU:A39) has a EV-to-FCF of 4.74 as of Jul. 02, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Arjo AB and its competitors. This is 54% below median its historical median of 10.24. Over the past decade, Arjo AB's EV-to-FCF has ranged from 4.61 to 22.79. According to the industry distribution chart, Arjo AB ranks #8 out of 75 companies in the Medical Distribution industry, placing it in the top 10.7%.
Is Arjo AB's EV-to-FCF too high?
Arjo AB's current EV-to-FCF of 4.74 is 54% below median its 10-year median of 10.24. Over the past 10 years, this metric has ranged from a low of 4.61 to a high of 22.79. The Medical Distribution industry median EV-to-FCF is 16.34. Arjo AB's value of 4.74 is 71% below this industry median. Based on the distribution chart, Arjo AB ranks #8 out of 75 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Arjo AB has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Arjo AB's EV-to-FCF compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Arjo AB ranks #8 out of 75 companies for EV-to-FCF. This places Arjo AB in the top 11% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 16.34. Arjo AB's value of 4.74 is 71% below this benchmark. Historically, Arjo AB's own EV-to-FCF has ranged from 4.61 to 22.79 over the past decade. While the company's 10-year median is 10.24 vs. the industry median of 16.34, Arjo AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 16.34, based on 75 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arjo AB's current EV-to-FCF of 4.74 is 71% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Arjo AB and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 16.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arjo AB's current EV-to-FCF is 4.74, which is 54% below median its own 10-year median of 10.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arjo AB stock overvalued right now?
Based on GuruFocus' analysis, Arjo AB (STU:A39) is currently considered Significantly Undervalued. The stock's GF Value™ is €3.41, compared to a current price of €2.25 — trading 34% below its estimated fair value. The current EV-to-FCF is 4.74, which is 54% below median its 10-year median of 10.24 and 71% below the Medical Distribution industry median of 16.34. Arjo AB's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Arjo AB (STU:A39), the current EV-to-FCF is 4.74 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arjo AB (STU:A39) Overvalued in 2026?
Based on GuruFocus' analysis, Arjo AB stock appears to be undervalued.
The current stock price of €2.25 is trading 34% below its estimated GF Value™ of €3.41.
GuruFocus considers Arjo AB to be Significantly Undervalued.
Key valuation signals for STU:A39:
EV-to-FCF: 4.74 (54% below median its 10-year median of 10.24)
GF Value™: €3.41 vs. price of €2.25 (34% below fair value)
Industry Position: 71% below the Medical Distribution median (#8 of 75)
No single metric tells the full story. See the STU:A39 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arjo AB is a supplier of medical devices, services, and solutions in Sweden. It serves its services to private and public institutions with acute care and long-term care. The company's offering includes products and solutions for patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism (VTE) prevention and diagnostics. The company includes segments: Global Sales, North America, Diagnostics.
68GF Score
Get the complete analysis for STU:A39
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:A39 has been successfully added to your 
